HIV-positive people with undetectable viral load pose ‘almost zero’ risk to sexual partners

Novo Nordisk will license three preclinical drug discovery programmes developed using Valo’s platform. Credit: Novo Nordisk. Novo Nordisk has signed an agreement with Valo Health for the

SAN DIEGO — BeiGene tout­ed longer fol­low-up da­ta for its can­cer drug Brukin­sa in re­lasped or re­frac­to­ry chron­ic lym­pho­cyt­ic leukemia Sat­ur­day, show­ing con­tin­ued im­prove­ments in